Consulta: creatorFacets:"MAMEDE,KARINA M."
Registros recuperados: 1
Data/hora: 02/06/2024 00:55:45

Antifibrotic effects of total or partial application of amniotic membrane in hepatic fibrosis
Provedor de dados: 42
Autores: MAMEDE,KARINA M.; SANT’ANNA,LUCIANA B.
Abstract: Liver fibrosis is the final common pathway of chronic liver diseases, having cirrhosis as a possible progression, which has liver transplantation as the only effective treatment. Human amniotic membrane represents a potential strategy as a therapy for liver fibrosis, due to its anti-inflammatory, anti-fibrotic and immunomodulatory properties. The aim of this study was to evaluate amniotic membrane effects as a treatment for hepatic fibrosis induced in rats by bile duct ligation (BDL), verifying alterations between two different forms of amniotic membrane application, around all the lobes of the liver and around only one lobe of the liver. Two weeks after inducing fibrosis, an amniotic membrane fragment was applied to the surface of the liver,...
Tipo: Info:eu-repo/semantics/article
Palavras-chave: Amniotic membrane; Histopathology; Immunohistochemistry; Liver fibrosis; Myofibroblasts.
Ano: 2019
URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652019000500702